Pitcairn CO Amgen Inc Transaction History

Pitcairn CO

$1.67 Billion
Q3 2024

A detailed history of Pitcairn CO transactions in Amgen Inc stock. As of the latest transaction made, Pitcairn CO holds 16,137 shares of AMGN stock, worth $4.39 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

16,137

Previous 17,625 8.44%

Holding current value

$4.39 Million

Previous $5.51 Million 5.58%

% of portfolio

0.31%

Previous 0.34%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $460,357 - $502,021	-1,488 Reduced 8.44%	16,137 $5.2 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $451,404 - $548,574	1,718 Added 10.8%	17,625 $5.51 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $136,854 - $165,201	509 Added 3.31%	15,907 $4.52 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $518,048 - $584,419	2,026 Added 15.15%	15,398 $4.43 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $97,955 - $121,614	-448 Reduced 3.24%	13,372 $3.59 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $640,024 - $756,816	-2,987 Reduced 17.77%	13,820 $3.07 Million
Q1 2023 May 05, 2023	SELL	$225.79 - $275.2 $150,376 - $183,283	-666 Reduced 3.81%	16,807 $4.06 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $162,382 - $206,326	709 Added 4.23%	17,473 $4.59 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $339,607 - $383,015	-1,513 Reduced 8.28%	16,764 $3.78 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $387,362 - $431,066	1,679 Added 10.12%	18,277 $4.45 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $44,731 - $49,484	204 Added 1.24%	16,598 $4.01 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $653,519 - $747,893	3,286 Added 25.07%	16,394 $3.69 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $181,915 - $213,135	857 Added 7.0%	13,108 $2.79 Million
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $6,540 - $7,255	-28 Reduced 0.23%	12,251 $2.99 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $296,027 - $344,972	-1,334 Reduced 9.8%	12,279 $3.06 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $1.07 Million - $1.27 Million	-4,936 Reduced 26.61%	13,613 $3.13 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $475,166 - $528,423	-2,025 Reduced 9.84%	18,549 $4.72 Million
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $291,176 - $357,313	-1,472 Reduced 6.68%	20,574 $4.85 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $566,948 - $751,928	3,111 Added 16.43%	22,046 $4.47 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $836,875 - $1.08 Million	4,423 Added 30.48%	18,935 $4.57 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $64,594 - $77,398	371 Added 2.62%	14,512 $2.81 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $430,919 - $505,134	-2,585 Reduced 15.45%	14,141 $2.61 Million
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $408,585 - $460,564	2,259 Added 15.61%	16,726 $3.18 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $853,644 - $996,476	4,785 Added 49.42%	14,467 $2.82 Million
Q3 2018 Nov 02, 2018	BUY	$185.29 - $208.89 $768,953 - $866,893	4,150 Added 75.02%	9,682 $2.01 Million
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $22,250 - $24,992	-134 Reduced 2.36%	5,532 $1.02 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $329,202 - $384,714	-1,943 Reduced 25.54%	5,666 $966,000
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $169,296 - $189,155	1,003 Added 15.18%	7,609 $1.32 Million
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $1.11 Million - $1.26 Million	6,606	6,606 $1.23 Million

Others Institutions Holding AMGN

# of Institutions

3,097

Shares Held

406M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

News

Stay updated on Pitcairn CO with notifications on news.

Account